The UCI announces that the Anti-Doping Tribunal has issued a decision against French rider Franck Bonnamour. The Tribunal has established that the French rider committed an anti-doping rule violation (ADRV) for the use of a prohibited substance or prohibited method due to an inexplicable anomaly in his athlete biological passport (*) in 2022. Consequently, the Tribunal has imposed a four-year period of ineligibility on the rider.

The period of ineligibility began on February 5, 2024, and will remain in effect until February 4, 2028, in compliance with the World Anti-Doping Code and UCI Anti-Doping Rules.

Additionally, in line with the Anti-Doping Tribunal's Procedural Norms, the decision will be published on the UCI website. The decision can be appealed to the Court of Arbitration for Sport (CAS) within one month.

(*) The athlete biological passport (ABP) is an individual electronic register for each cyclist, where the results of all anti-doping tests collected under the ABP program in a specific period are recorded. The International Testing Agency (ITA), the independent body to which the UCI has delegated its anti-doping program while maintaining responsibility for results management and prosecution of anti-doping rule violations, manages the ABP program in collaboration with the Athlete Passport Management Unit (APMU) in Lausanne, Switzerland (the Lausanne APMU is associated with the World Anti-Doping Agency accredited Laboratory in Lausanne). Athletes' biological cases are pursued based on the opinion of an independent expert group from the APMU.